Rheumatic diseases can seriously complicate everyday life, especially when traditional treatments do not bring the desired results. This condition can be very exhausting for affected individuals who are constantly struggling with pain and limited mobility. However, there is no need to despair, as science is on the verge of important discoveries that promise better days.
Our scientific research, aimed at treating rheumatic diseases, is in full swing. Clinical studies are currently being conducted worldwide, exploring the possibilities of using mesenchymal stem/stromal cells, better known as MSCs. These cells are real little miracles in medicine – they specialize in repairing damaged tissue and are extremely promising in the treatment of inflammatory rheumatic diseases due to their regenerative power.
The use of MSCs has been evaluated as safe, and patients report noticeable improvements in their condition. Not only are the findings better, but their overall well-being and ability to perform daily activities are also improving.
Early study results show that the use of MSCs is safe. Patients who have opted for this treatment notice an improvement in their laboratory and clinical findings.
MSC are multipotent cells that can differentiate into mesodermal cell lineages, such as adipocytes, osteocytes, and chondrocytes. MSC were initially isolated from bone marrow, but it is now known that they are found in almost all tissues (e.g., adipose tissue, umbilical cord, etc.). MSC have the ability to migrate to the site of injury in the body, where they can differentiate and replace damaged cells, as well as promote tissue regeneration. Additionally, they have the capacity for paracrine signaling and cell-to-cell communication by secreting various soluble factors and extracellular vesicles. In an inflammatory environment, they act immunomodulatory on different cells of the innate and adaptive immune systems, which is one of their main properties exploited for therapeutic purposes.
They can be used for local tissue regeneration or for their systemic effects.
It is important to know that PRP treatment is not the same as our therapy. PRP treatment uses only 1 to 3 stem cells, while our therapy uses a dosed amount of 15 to 20 million stem cells.
We at GaiaCell are a biotechnology company specialized in safe and effective cell therapies in orthopedics, hematooncology, pulmonology and other therapeutic areas. Our high-tech laboratories with GMP certificate and research center guarantee the highest quality and innovation. We also offer contract development and manufacturing (CDMO), ensuring top-notch project execution.